title: Antibodies to the high-density lipoprotein receptor SR-B1 potently inhibit hepatitis C virus replication in vivo: New avenues for preventing reinfection of the liver following transplantation.
authors: Viral Fusion Laboratory, Centre for Biomedical Research, Burnet Institute, Melbourne, Australia; Department of Microbiology, Monash University, Clayton, Australia; Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Parkville, Australia.
authors: Heidi E
authors: HE
authors: Drummer
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D006526:Hepatitis C / Q000188:drug therapy*; D006801:Humans; D051122:Scavenger Receptors, Class B / Q000276:immunology*
chemical_list: D000911:Antibodies, Monoclonal; C495124:SCARB1 protein, human; D051122:Scavenger Receptors, Class B